Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer-Reference-Cited by-同舟云学术

Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer

Published:2010 Issue: Volume: Page:NA-NA
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Aleskandarany Mohammed A.,Green Andrew R.,Rakha Emad A.,Mohammed Rabab A.,Elsheikh Somaia E.,Powe Desmond G.,Paish Emma C.,Macmillan R. Douglas,Chan Steve,Ahmed Samreen I.,Ellis Ian O.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Molecular evolution of breast cancer;Simpson;J Pathol,2005

2. Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer;Suen;Biomed Pharmacother,2006

3. Prognostic factors observed in current clinical-trials;Dorr;Cancer,1993

4. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study;Bertelsen;J Natl Cancer Inst,2008

5. Norwegian Breast Cancer Group (NBCG). Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients-longterm follow-up;Fjosne;Eur J Surg Oncol,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer;Laboratory Investigation;2024-05

2. A Spatially Resolved Mechanistic Growth Law for Cancer Drug Development Predicting Tumor Growing Fractions;Cancer Research Communications;2022-08-02

3. Visual and digital assessment of Ki-67 in breast cancer tissue - a comparison of methods;Diagnostic Pathology;2022-05-06

4. Pathophysiologic and Pharmacologic Considerations to Improve the Design and Application of Antibody–Drug Conjugates;Cancer Research;2022-03-17

5. Analysis of Ki-67 expression in women with breast cancer: Comparative evaluation of two different methodologies by immunophenotyping;Pathology - Research and Practice;2022-02